Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
6.–10. rezultāts no 29.
369. lappuse
... Cephalexin Not dried 1 mg 7 days Cephaloglycin Not dried Distilled water 100 μg 1 week 1 1 mg 5 days Cephaloridine 1 1 1 mg 5 days Cephalothin 1 1 1 mg 3 days Cephapirin Not dried Cephradine Not dried 1 1 mg ....... 5 days Distilled ...
... Cephalexin Not dried 1 mg 7 days Cephaloglycin Not dried Distilled water 100 μg 1 week 1 1 mg 5 days Cephaloridine 1 1 1 mg 5 days Cephalothin 1 1 1 mg 3 days Cephapirin Not dried Cephradine Not dried 1 1 mg ....... 5 days Distilled ...
380. lappuse
... Cephalexin Cephaloridine Cephalothin Cephapirin Cloxacillin Cyclacillin Dicloxacillin Methicillin Nafcillin Oxacillin None Distilled water ... ...... do ...... do 1.0 mg . 1.25 mg . ...... do ...... do 2 mg . ...... do ...... do 2 mg ...
... Cephalexin Cephaloridine Cephalothin Cephapirin Cloxacillin Cyclacillin Dicloxacillin Methicillin Nafcillin Oxacillin None Distilled water ... ...... do ...... do 1.0 mg . 1.25 mg . ...... do ...... do 2 mg . ...... do ...... do 2 mg ...
381. lappuse
... Cephalexin ...... do ...... do 2 mg . Cephaloridine ...... do ...... do 2 mg . Cephalothin sodium ...... do ...... do 2 mg . Cephapirin sodium .... do ...... do 2 mg . Cloxacillin sodium monohydrate ...... do ...... do 1.25 mg ...
... Cephalexin ...... do ...... do 2 mg . Cephaloridine ...... do ...... do 2 mg . Cephalothin sodium ...... do ...... do 2 mg . Cephapirin sodium .... do ...... do 2 mg . Cloxacillin sodium monohydrate ...... do ...... do 1.25 mg ...
389. lappuse
... Cephalexin hydrochloride monohydrate tablets .. Cephradine dihydrate capsules . Clarithromycin tablets . Doxycycline hyclate tablets . Doxycycline monohydrate hydrochloric❘ acid capsules .. Erythromycin particles in tablets Loracarbef ...
... Cephalexin hydrochloride monohydrate tablets .. Cephradine dihydrate capsules . Clarithromycin tablets . Doxycycline hyclate tablets . Doxycycline monohydrate hydrochloric❘ acid capsules .. Erythromycin particles in tablets Loracarbef ...
392. lappuse
... Cephalexin hydrochloride monohydrate . Assay for cephalexin ac- tivity of the cephalexin hydrochloride monohydrate as directed in §442.28 of this chapter , and use U.S.P. dissolution apparatus 1 ( 10 mesh basket ) . Use the sample as it ...
... Cephalexin hydrochloride monohydrate . Assay for cephalexin ac- tivity of the cephalexin hydrochloride monohydrate as directed in §442.28 of this chapter , and use U.S.P. dissolution apparatus 1 ( 10 mesh basket ) . Use the sample as it ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning